Global Interventional Cardiovascular Devices Market Size By Type (Imaging System, Catheter), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Interventional Cardiovascular Devices Market was valued at USD 15.4 billion in 2023 and is projected to surpass USD 28.9 billion by 2031, growing at a CAGR of 8.3% during the forecast period from 2023 to 2031. The increasing prevalence of cardiovascular diseases (CVDs), rising geriatric population, and advances in minimally invasive procedures are major drivers of this market. Interventional cardiovascular devices, including stents, catheters, and angioplasty balloons, play a vital role in managing and treating heart-related disorders, offering faster recovery and improved patient outcomes.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

With CVDs being a leading cause of death globally, the demand for interventional procedures such as angioplasty and stenting continues to increase. The shift towards early diagnosis and preventive interventions is accelerating the adoption of these devices.

2. Technological Advancements in Devices:

Innovations such as bioresorbable stents, drug-eluting balloons, and imaging-guided interventions have improved the efficacy and safety of cardiovascular treatments, leading to higher market acceptance and clinical success.

3. Growth in Geriatric Population:

An aging global population contributes significantly to the burden of heart diseases, creating a larger patient base requiring interventional cardiac care.

Restraints:

1. High Cost of Procedures and Devices:

The high cost associated with advanced interventional cardiovascular devices and procedures limits accessibility, especially in low- and middle-income countries.

2. Stringent Regulatory Approval:

Rigorous regulatory pathways for the approval of new cardiovascular devices can delay product launches, impacting market expansion.

Opportunity:

1. Emerging Markets and Healthcare Infrastructure Improvements:

Rapid urbanization, rising healthcare expenditure, and expanding hospital infrastructure in regions like Asia-Pacific and Latin America provide lucrative opportunities for market growth.

2. Integration of Imaging and AI Technologies:

The integration of artificial intelligence, 3D imaging, and robotics in interventional cardiology enhances precision and diagnostic accuracy, opening new avenues for development and commercialization.

Market by System Type Insights:

By system type, Coronary Stents dominated the market in 2023. These devices are extensively used in the treatment of coronary artery disease, which remains the most prevalent form of CVD. Catheters and guidewires are anticipated to register the fastest growth due to their essential role in a broad range of interventional procedures and increasing adoption in minimally invasive techniques.

Market by End-use Insights:

Based on end-use, Hospitals accounted for the largest market share in 2023, driven by their advanced facilities, skilled personnel, and capacity to perform complex interventions. Ambulatory Surgical Centers (ASCs) are expected to grow at a higher pace owing to lower procedural costs and shorter recovery times that appeal to patients and healthcare providers alike.

Market by Regional Insights:

North America held the largest share of the global market in 2023, fueled by a high prevalence of CVDs, favorable reimbursement scenarios, and robust healthcare infrastructure. Asia-Pacific is projected to witness the highest growth rate through 2031, attributed to increasing healthcare investments, improving access to advanced medical technologies, and growing awareness of heart health in countries such as China and India.

Competitive Scenario:

Key players in the Global Interventional Cardiovascular Devices Market include:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

Terumo Corporation

B. Braun Melsungen AG

Cordis (a Cardinal Health company)

BIOTRONIK SE & Co. KG

Biosensors International Group, Ltd.

Meril Life Sciences

MicroPort Scientific Corporation

These companies focus on technological innovations, product approvals, and mergers & acquisitions to strengthen their market presence. For example:

In 2024, Abbott Laboratories received FDA approval for its next-generation drug-eluting stent with enhanced deliverability.

Boston Scientific launched a novel catheter-based imaging system in 2023 to support complex coronary interventions.

In 2025, Medtronic expanded its portfolio of interventional tools through the acquisition of a catheter device start-up specializing in neurovascular applications.

Scope of Work – Global Interventional Cardiovascular Devices Market

Report Metric Details

Market Size (2023) USD 15.4 billion

Projected Market Size (2031) USD 28.9 billion

CAGR (2023-2031) 8.3%

Market Segments System Type (Stents, Catheters, Balloons), End-Use, Region

Growth Drivers Rising prevalence of CVDs, geriatric population, tech advancements

Opportunities Expansion in emerging markets, AI integration in interventions

Key Market Developments:

June 2024: Medtronic launched a real-time imaging-supported stent deployment platform aimed at reducing procedural risks.

March 2024: Boston Scientific partnered with a leading Asian healthcare group to enhance the availability of interventional cardiovascular devices in underserved markets.

January 2023: Abbott introduced a next-generation balloon catheter designed for enhanced flexibility and patient safety.

FAQs:

1) What is the current market size of the Global Interventional Cardiovascular Devices Market?

The market was valued at USD 15.4 billion in 2023.

2) What is the major growth driver of the Global Interventional Cardiovascular Devices Market?

The rising prevalence of cardiovascular diseases and the adoption of minimally invasive procedures are key growth drivers.

3) Which is the largest region during the forecast period in the Global Interventional Cardiovascular Devices Market?

North America leads the market in terms of share, while Asia-Pacific is projected to grow the fastest.

4) Which segment accounted for the largest market share in Global Interventional Cardiovascular Devices Market?

The Coronary Stents segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Interventional Cardiovascular Devices Market?

Key players include Medtronic, Boston Scientific, Abbott Laboratories, Terumo Corporation, and B. Braun Melsungen AG.